Avalon GloboCare (ALBT) Competitors $2.14 +0.05 (+2.39%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.10 -0.04 (-1.64%) As of 08/22/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALBT vs. MTEX, SYBX, LPCN, LEXX, BLRX, TRIB, EDSA, MTVA, LSB, and HOTHShould you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include Mannatech (MTEX), Synlogic (SYBX), Lipocine (LPCN), Lexaria Bioscience (LEXX), BioLineRx (BLRX), Trinity Biotech (TRIB), Edesa Biotech (EDSA), MetaVia (MTVA), LakeShore Biopharma (LSB), and Hoth Therapeutics (HOTH). These companies are all part of the "pharmaceutical products" industry. Avalon GloboCare vs. Its Competitors Mannatech Synlogic Lipocine Lexaria Bioscience BioLineRx Trinity Biotech Edesa Biotech MetaVia LakeShore Biopharma Hoth Therapeutics Mannatech (NASDAQ:MTEX) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends. Which has higher valuation & earnings, MTEX or ALBT? Mannatech has higher revenue and earnings than Avalon GloboCare. Mannatech is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMannatech$117.87M0.14$2.49M-$2.04-4.17Avalon GloboCare$1.33M6.18-$7.90M-$19.96-0.11 Is MTEX or ALBT more profitable? Mannatech has a net margin of -3.46% compared to Avalon GloboCare's net margin of -1,451.94%. Avalon GloboCare's return on equity of 0.00% beat Mannatech's return on equity.Company Net Margins Return on Equity Return on Assets Mannatech-3.46% -48.60% -10.70% Avalon GloboCare -1,451.94%N/A -75.12% Do insiders and institutionals hold more shares of MTEX or ALBT? 13.0% of Mannatech shares are held by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are held by institutional investors. 41.5% of Mannatech shares are held by insiders. Comparatively, 37.3% of Avalon GloboCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, MTEX or ALBT? Mannatech has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500. Does the media refer more to MTEX or ALBT? In the previous week, Avalon GloboCare had 1 more articles in the media than Mannatech. MarketBeat recorded 1 mentions for Avalon GloboCare and 0 mentions for Mannatech. Avalon GloboCare's average media sentiment score of 1.11 beat Mannatech's score of 0.00 indicating that Avalon GloboCare is being referred to more favorably in the news media. Company Overall Sentiment Mannatech Neutral Avalon GloboCare Positive SummaryMannatech beats Avalon GloboCare on 8 of the 13 factors compared between the two stocks. Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALBT vs. The Competition Export to ExcelMetricAvalon GloboCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.02M$3.11B$5.76B$9.58BDividend YieldN/A2.23%4.41%4.10%P/E Ratio-0.1120.8831.1026.04Price / Sales6.18343.33433.45102.77Price / CashN/A43.1937.7358.48Price / Book-0.428.129.536.61Net Income-$7.90M-$54.72M$3.26B$265.56M7 Day Performance-6.14%2.63%2.10%1.97%1 Month Performance-10.08%2.78%2.81%-0.36%1 Year Performance-52.96%11.01%30.56%19.03% Avalon GloboCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALBTAvalon GloboCare1.3087 of 5 stars$2.14+2.4%N/A-55.4%$8.02M$1.33M-0.115News CoveragePositive NewsShort Interest ↑MTEXMannatech0.2783 of 5 stars$8.65+8.1%N/A+18.8%$16.44M$117.87M-86.50250Gap UpSYBXSynlogic0.3946 of 5 stars$1.37-2.1%N/A-3.3%$16.38M$10K-0.5680Short Interest ↑LPCNLipocine2.4829 of 5 stars$3.00+2.4%$9.00+199.9%-16.2%$16.29M$11.20M-3.4510News CoverageAnalyst ForecastAnalyst RevisionGap UpLEXXLexaria Bioscience3.3987 of 5 stars$0.82-0.5%$4.00+389.6%-73.8%$15.98M$460K-1.227BLRXBioLineRx3.4297 of 5 stars$3.72+4.5%$26.00+598.9%-87.0%$15.85M$28.94M-0.4240TRIBTrinity Biotech1.4712 of 5 stars$0.89+6.7%N/A-29.6%$15.83M$61.56M-0.30480Upcoming EarningsGap DownEDSAEdesa Biotech1.5634 of 5 stars$2.18+3.4%$5.00+129.3%-46.1%$15.75MN/A-1.7020MTVAMetaVia2.124 of 5 stars$0.65+1.8%$7.50+1,053.8%N/A$15.73MN/A0.008LSBLakeShore Biopharma0.6383 of 5 stars$0.75-6.9%N/A-81.2%$15.49M$85.67M0.00773Gap DownHOTHHoth Therapeutics2.2032 of 5 stars$1.17+0.5%$4.00+243.1%+79.1%$15.46MN/A-1.034News CoverageAnalyst DowngradeShort Interest ↓ Related Companies and Tools Related Companies Mannatech Competitors Synlogic Competitors Lipocine Competitors Lexaria Bioscience Competitors BioLineRx Competitors Trinity Biotech Competitors Edesa Biotech Competitors MetaVia Competitors LakeShore Biopharma Competitors Hoth Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALBT) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access